An optimized method for intensive screening of molecules that stimulate beta-defensin 2 or 3 (hBD2 or hBD3)

I Pernet1, C Reymermier, A Guezennec

  • 1Inserm U346, Clinique Dermatologique, Hôpital E. Herriot, Lyon, France.

Related Concept Videos